Contents:
- Medical Video: Breast cancer and osteoporosis: the link between them
- Is raloxifene able to reduce the risk of breast cancer?
- What are the side effects of using Raloxifen?
- Who can use raloxifene?
Medical Video: Breast cancer and osteoporosis: the link between them
Raloxifene is an estrogen receptor modulator that functions against estrogen in body tissues, but other contents can also act like estrogen. Estrogen can trigger the growth of breast cancer cells. Ralofixene is useful for preventing and treating osteoporosis in women after menopause. Therefore, raloxifene is only allowed for women who have experienced menopause. To reduce the risk of breast cancer, patients can treat for five years.
Is raloxifene able to reduce the risk of breast cancer?
Raloxifene is one drug that can reduce the risk of breast cancer. Tamoxifen or raloxifene can block estrogen in breast cancer cells so that it can reduce the risk of breast cancer. However, raloxifene does not have estrogen-like functions in the uterus.
Recent studies have shown that raloxifene decreases the risk of breast cancer for women who have experienced menopause as much as 18 to 58%. Other studies are needed to determine the further effects of using raloxifene.
What are the side effects of using Raloxifen?
Side effects of raloxifene include the body feeling hot, leg cramps, swelling of the feet and hands, weight gain, stroke, blood clots, and pain during intercourse. The use of raloxifene has a low level of risk in blood clots. This might be an option for women who have experienced menopause because this treatment does not cause uterine cancer or osteoporosis.
Side effects of raloxifene include:
- The female area becomes dry
- Muscle ache
- Overweight
Health risks related to raloxifene are similar to the risks that will arise in the use of tamoxifen. Raloxifene has less potential to cause stroke than tamoxifen, but the average cancer patient who does this treatment is more likely to be at risk for heart disease. In addition, raloxifene can increase the risk of stroke if the patient already has heart disease or has supporting factors that cause heart disease.
Who can use raloxifene?
Raloxifene can be used to reduce the risk of invasive breast cancer after passing menopause. The magnitude of the risk of breast cancer is shown by achieving the 1.66 figure on the Gail model.
